← Eichor
Condition: Lenacapavir Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lenacapavir

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06819176The TAIL-PrEP Study
NA · 1 location(s) · Columbia University · NCT06868641ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention
NA · 8 location(s) · Oswaldo Cruz Foundation · NCT07497594HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT04979728Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County
Phase N/A · 1 location(s) · University of California, Los Angeles · NCT07467018A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · 3 location(s) · Gilead Sciences · NCT07645287Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France
Phase N/A · 1 location(s) · Centre de Recherches et d'Etude sur la Pathologie Tropicale · NCT06799338Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa ( PROTECT-L)
NA · 1 location(s) · University of Pennsylvania · NCT07518914Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adult
Phase 3 · 3 location(s) · Gilead Sciences · NCT07682961Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
Phase 4 · 1 location(s) · Duke University · NCT07218211Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
Phase 2 · 9 location(s) · Gilead Sciences · NCT06749054Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Phase N/A · 31 location(s) · Gilead Sciences · NCT07473778
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.